General Physicians witness the full picture of what works and what does not work in today’s healthcare system. They see medications that fall short, patients who don’t respond to standard treatment, conditions that go undiagnosed for too long, and chronic illnesses shaped by social and economic realities. Whether it’s a rural clinic managing high-risk patients with limited tools or an urban practice seeing patterns in comorbidities, General Physicians collect a level of insight that no clinical trial or algorithm can fully replicate.  

Yet, despite being so close to the reality of patient care, these frontline insights often remain undocumented, unshared, and underutilized for healthcare breakthroughs. But here’s the thing – these real-world experiences are precisely what researchers, pharmaceutical companies, and public health organizations need to drive practical, effective medical innovation. This is where MDForLives steps in, creating a direct channel between General Physicians and the people shaping medical breakthroughs. 

What is MDForLives? 

MDForLives is a trusted, global community of licensed healthcare professionals who contribute to medical research by sharing their real-world clinical expertise. 

Through short, focused, and compensated medical surveys, General Physicians (GPs) on the platform offer insights drawn from their daily interactions with patients. These are not hypothetical scenarios but observations from the frontlines of primary care. With over 40,000 GPs actively taking paid surveys, MDForLives has become one of the largest and most engaged networks of primary care providers in research collaboration for healthcare breakthroughs. 

What sets the platform apart is its ability to connect frontline clinical voices with key decision-makers across the healthcare ecosystem. MDForLives works closely with leading pharmaceutical companies, clinical research organizations, public health bodies, and regulatory stakeholders who depend massively on practitioners’ inputs to guide everything from early drug development to post-marketing studies and public health initiatives. 

For GPs, this is more than just survey participation. It is an opportunity to shape the very systems and solutions they work within. Whether the focus is on optimizing treatment protocols, identifying unmet patient needs, or exploring new technology adoption in primary care, MDForLives ensures that the feedback collected directly informs meaningful change.  

Why Did 40K General Physicians Choose MDForLives? 

Time may be limited, but the drive to make a meaningful impact on medicine is still strong among General Physicians. That’s why so many turn to MDForLives. We are one of those few healthcare survey platforms, which is designed with each healthcare professional’s (no matter their specialty) realities in mind. It offers the flexibility to participate in clinically relevant, research-backed surveys whenever their schedule allows.  

Whether between patients or after hours, GPs can share their expertise, contribute to important healthcare studies, and receive fair compensation, all without disrupting their day-to-day responsibilities. But what keeps physicians coming back isn’t just honoraria. It is the knowledge that their responses are part of something bigger, be it – fueling innovation in drug safety, diagnostic tools, treatment access, and more.  

MDForLives turns everyday clinical wisdom into research that matters, and GPs value being part of that.

How MDForLives Collaborates with General Physicians to Drive Medical Breakthrough?  

The collaboration between MDForLives and General Physicians is rooted in mutual values. GPs bring their real-world clinical experience to the table, offering insights that research teams often can’t access through trials alone. In return, they receive fair compensation, professional recognition, and the deeper satisfaction of contributing to improvements in medicine that extend far beyond their own practice. 

Here’s how this collaboration comes to life: 

1. Targeted Medical Surveys: General Physicians take paid surveys on MDForLives that delve into the realities of everyday clinical practice including treatment gaps, patient behavior, and medication usage.  

These surveys are designed to capture the nuances of real-world care. GPs share what happens when patients struggle with adherence, report side effects, or abandon treatment altogether. In short, the insights that can significantly influence how therapies are designed, prescribed, and supported. 

Example (Latest Survey): 

What Was the Survey About? 

The objective was to gather first-hand insights from GPs on their perception, confidence, and prescribing behaviors related to biosimilar drugs. With the rise of biosimilars as cost-effective alternatives to originator biologics, the survey aimed to understand how comfortable GPs are with this shift, what influences their prescribing choices, and how these decisions differ across healthcare systems globally. 

Who Took the Survey?

The survey was conducted exclusively among General Physicians (GPs) – a total of 8,500+ respondents from five countries: United States, United Kingdom, Germany, Italy, and Canada. 

 What Was the Outcome?

The findings show that GPs globally are becoming increasingly receptive to biosimilar drugs, though the pace and extent of adoption vary. 

  • Italy and Germany reported the highest levels of biosimilar replacement and confidence in switching stable patients. 
  • The U.S. and U.K. GPs showed moderate adoption, balancing cost considerations with clinical evidence. 
  • Canadian GPs remained the most cautious, with limited biosimilar usage and lower confidence levels.

Clinical trial data and cost-effectiveness emerged as the primary drivers behind GPs’ decision to switch to biosimilars. Most GPs across all countries reported no clinical concerns or adverse events during the switch, reinforcing overall trust in biosimilars. Meanwhile, factors like regulatory guidance, patient preference, and institutional policy played a smaller, though regionally varied, role in influencing adoption. 

Want to learn about the full insight on Biosimilar adoption? Click here.

How Did Our Panelists (GPs) Help Researchers? 

GPs, through their daily experiences and decision-making, provided ground-level data on what truly influences biosimilar adoption. Their input helped researchers identify both enablers (cost savings, trust in clinical evidence) and barriers (patient resistance, lack of long-term real-world data).  

This is one of the many examples that showcase how General Physicians, who have joined MDForLives and have taken relevant medical surveys, have contributed immensely to healthcare research.  

2. Clinical Experience in Research Design: With firsthand knowledge of how treatments perform in real-world settings, General Physicians offer crucial input that shapes clinical trial design and post-marketing studies. Their insights into patient behavior, response variability, and diagnostic challenges help make research more practical, inclusive, and clinically relevant. 

3. Technology Evaluation & Innovation: As digital tools and AI increasingly shape the future of healthcare, the input of General Physicians is essential in ensuring these innovations work in real-world settings. 

GPs on MDForLives are often invited to test and evaluate emerging health technologies including mobile health apps, clinical decision support tools, AI-based diagnostics, and telemedicine platforms. Their feedback helps developers understand what works well, what needs improvement, and how these tools can be seamlessly integrated into everyday clinical workflows. 

4. Policy and Public Health Guidance: As primary touchpoints for diverse patient populations, General Physicians offer perspectives that are vital for shaping effective public health strategies. Through MDForLives, their collective insights reveal real-world patterns, barriers, and health trends. These findings support governments, NGOs, and health agencies in developing more focused, impactful, and locally relevant public health interventions. 

What General Physicians Stand to Gain by Sharing Insights with MDForLives? 

Every time a General Physician shares their perspective on MDForLives, it contributes far greater than data. It becomes a force behind medical breakthroughs, smarter care, and meaningful change.  

Here’s what GPs truly gain from taking paid surveys: 

  • Real Influence on Medical Innovation: Your insights are used to improve drug development, refine treatment protocols, and shape clinical guidelines based on what actually works in real-world care. 
  • A Seat at the Table: Join a global community of physicians who are actively shaping healthcare not as subjects, but as co-creators of better systems and solutions. 
  • Professional Fulfillment: Feel the satisfaction of knowing your everyday clinical experiences are being used to solve bigger problems in medicine and public health. 
  • Collaborative Impact: Engage in conversations with fellow GPs across diverse geographies, comparing challenges, strategies, and solutions that enrich your own practice. 
  • Lump-Sum Earnings: For each survey you complete, receive substantial financial compensation that respects your time and expertise – NO DELAYS GUARNATEED! 
Join Us, Be a Part of Something Bigger! 

Register with MDForLives

At MDForLives, we are actively working with leading pharmaceutical companies, research organizations, and public health teams to spark the next wave of medical breakthroughs. And we are doing it with the insights of General Physicians who see the real-world challenges of healthcare every day. 

When you share your clinical experiences, you are contributing to solutions that go far beyond your own practice. You are helping shape treatments, technologies, and strategies that can transform care for entire communities, or sometimes, even countries and continents! 

So, join us and do more than just care for the patients in front of you. Use your voice to influence the future of medicine!